Skip to main content
 

BioIntelliSense Recognized as the “Best Overall Medical Device Company” for 2023 in the 7th Annual MedTech Breakthrough Awards Program

BioIntelliSense Recognized as the “Best Overall Medical Device Company” for 2023 in the 7th Annual MedTech Breakthrough Awards Program

MedTech Breakthrough selects BioIntelliSense with its BioButton® multi-parameter, medical grade wearable device and advanced clinical intelligence solutions as the “2023 Best Overall Medical Device Company.” BioIntelliSense continues to deliver breakthrough clinical intelligence solutions for scalable continuous patient monitoring and tech-enabled care.

Read more here

More News

  • HeartBeam, AccurKardia partner to speed up cardiac diagnosis

  • AccurKardia’s AccurECG Named “Best New Technology Solution for ECG” in 9th Annual MedTech Breakthrough Awards Program

  • HeartBeam and AccurKardia Announce Strategic Collaboration to Advance Cardiac Monitoring Innovation